Chemours Publishes Revised 2025 Annual Report

• Chemours amended its 2025 annual report, revising its conclusion to show disclosure controls were ineffective as of December 31, 2025.
• An administrative error omitted management's internal control report from the original February 24, 2026 filing; consolidated financial statements remain unchanged.
• Internal control over financial reporting remained effective, with PricewaterhouseCoopers issuing an unqualified opinion.
• Disclosure controls remained ineffective until the third quarter of 2026, when management implemented additional reviews of non-financial disclosures.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. The Chemours Company published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-122164), on November 03, 2026, and is solely responsible for the information contained therein.